A new study has found that the risk of serious bleeding is similar when taking the blood thinners apixaban and dabigatran compared to aspirin. However, the blood thinner rivaroxaban has a higher ...

Lower risk for bleeding without increase in ischemic events seen for patients with acute coronary syndrome.

Cancer diagnoses tended to arise more in patients who bled on oral anticoagulants (OACs), a Canadian population-based cohort ...

Cerebral venous thrombosis is a rare but potentially life-threatening condition that is particularly prevalent in young women (ie, mean age 44 years) and accounts for 0·5–3% of all strokes. The ...

Patients affected by sinus thrombosis are treated with blood thinners. Traditionally, these patients are prescribed vitamin K antagonists (VKAs). In order to give the correct dosage, regular check-ups ...

A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Novartis has announced its acquisition of Anthos Therapeutics, a Boston-based biopharmaceutical company focused on developing abelacimab, an inve ...

Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rates are ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

I am a 67-year-old male with generally good vision. I have had a few floaters in my eyes over the years, but they have generally been small ...